Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hagan

Showing results (71-80 of 274) with videos related to

Pageof 28
Sort By:
Plant Physiology|May 1, 1972
Some counteractive effects of antitranspirantsD C Davenport, M A Fisher, R M Hagan
Health Affairs (Project Hope)|January 1, 1988
How the U.S. spent its health care dollar: 1929-1980M L Berk, A C Monheit, M M Hagan
Hepatology (Baltimore, Md.)|March 29, 2014
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individualsLiesl M Hagan, Mark S Sulkowski, Raymond F Schinazi
Molecular and Cellular Biochemistry|December 14, 2002
The effect of charge reversal mutations in the alpha-helical region of liver fatty acid binding protein on the binding of fatty-acyl CoAs, lysophospholipids and bile acidsRobert M Hagan, Joanna K Davies, David C Wilton
Canadian Journal of Physiology and Pharmacology|July 1, 1995
Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headacheD T Beattie, H E Connor, R M Hagan
Behavioural Brain Research|January 1, 1996
5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic systemG J Kilpatrick, R M Hagan, J D Gale
The Journal of Biological Chemistry|November 16, 2004
Tryptophan insertion mutagenesis of liver fatty acid-binding protein: L28W mutant provides important insights into ligand binding and physiological functionRobert M Hagan, Jane Worner-Gibbs, David C Wilton
American Journal of Pharmaceutical Education|July 24, 2021
Addressing the Need for Ethnic and Racial Diversity in the Pipeline for Pharmacy FacultyHope E Campbell, Angela M Hagan, Caroline A Gaither
The Biochemical Journal|October 16, 2007
The interaction of liver fatty-acid-binding protein (FABP) with anionic phospholipid vesicles: is there extended phospholipid anchorage under these conditions?Robert M Hagan, Jane Worner-Gibbs, David C Wilton
IEEE Transactions on Bio-Medical Engineering|July 1, 2016
Radiotherapy Planning Using an Improved Search Strategy in Particle Swarm OptimizationArezoo Modiri, Xuejun Gu, Aaron M Hagan, et al.
Pageof 28

Showing results (71-80 of 274) with videos related to

Sort By:
Pageof 28
Plant Physiology|May 1, 1972
Some counteractive effects of antitranspirantsD C Davenport, M A Fisher, R M Hagan
Health Affairs (Project Hope)|January 1, 1988
How the U.S. spent its health care dollar: 1929-1980M L Berk, A C Monheit, M M Hagan
Hepatology (Baltimore, Md.)|March 29, 2014
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individualsLiesl M Hagan, Mark S Sulkowski, Raymond F Schinazi
Molecular and Cellular Biochemistry|December 14, 2002
The effect of charge reversal mutations in the alpha-helical region of liver fatty acid binding protein on the binding of fatty-acyl CoAs, lysophospholipids and bile acidsRobert M Hagan, Joanna K Davies, David C Wilton
Canadian Journal of Physiology and Pharmacology|July 1, 1995
Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headacheD T Beattie, H E Connor, R M Hagan
Behavioural Brain Research|January 1, 1996
5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic systemG J Kilpatrick, R M Hagan, J D Gale
The Journal of Biological Chemistry|November 16, 2004
Tryptophan insertion mutagenesis of liver fatty acid-binding protein: L28W mutant provides important insights into ligand binding and physiological functionRobert M Hagan, Jane Worner-Gibbs, David C Wilton
American Journal of Pharmaceutical Education|July 24, 2021
Addressing the Need for Ethnic and Racial Diversity in the Pipeline for Pharmacy FacultyHope E Campbell, Angela M Hagan, Caroline A Gaither
The Biochemical Journal|October 16, 2007
The interaction of liver fatty-acid-binding protein (FABP) with anionic phospholipid vesicles: is there extended phospholipid anchorage under these conditions?Robert M Hagan, Jane Worner-Gibbs, David C Wilton
IEEE Transactions on Bio-Medical Engineering|July 1, 2016
Radiotherapy Planning Using an Improved Search Strategy in Particle Swarm OptimizationArezoo Modiri, Xuejun Gu, Aaron M Hagan, et al.
Pageof 28